
The $30 Trillion Problem Healthcare Keeps Ignoring
Reactive health care models are projected to cost the global economy $30 trillion from 2011 to 2030, even as noncommunicable diseases kill over 43 million people each year, according to the World Health Organization (WHO).
PureHealth’s “Care & Cover” model integrates insurance and clinical delivery to align financial incentives with proactive treatment.
Using Abu Dhabi as a regulatory testbed, PureHealth is exporting its prevention-first model through acquisitions in the UK, US and Europe.
When Shaista Asif cofounded PureHealth in 2006, she recognized a fundamental flaw: Health care systems are organized to treat illness—not prevent it.
“Today, too many systems are designed to react after damage is done,” says Asif, Group CEO of PureHealth, the Middle East’s largest health care company, based in the UAE. “That model is economically unsustainable and morally indefensible.”
The statistics reflect Asif’s view: According to the WHO, noncommunicable diseases (NCDs), including cardiovascular diseases, cancers, chronic respiratory diseases and diabetes, are the leading cause of death and disability globally, even though many are preventable.
The WHO estimates that seven of the 10 leading causes of death in 2021 were attributed to NCDs, killing at least 43 million people that year.

Legacy payment structures, siloed provider data and fragmented patient care make it difficult for health systems to shift from treating illness to preventing it.
Data access is a significant barrier. Health care is heavily regulated, and data privacy requirements, legacy IT systems and poor interoperability keep patient information siloed across the care journey. In many clinical environments, records remain paper-based.
This fragmentation prevents clinicians from seeing a complete picture of a patient’s health, and often limits their ability to intervene early and prevent escalation of medical conditions. These challenges to proactive care and improved outcomes are costly, and the economic argument for prevention is now urgent. With aging populations and chronic disease driving health care spending toward 20% of GDP in the US, reactive care models are unsustainable, according to the Organisation for Economic Cooperation and Development.

According to Dr. Clair Sullivan, Director of the Queensland Digital Health Centre, at the University of Queensland in Brisbane, Australia, the new approach is a complete shift.“The new way is transformation,” says Sullivan. “It means moving from a provider-centered model to a consumer-centered one, where individuals have the data and support to make their own decisions. Today, providers treat disease. With the right tools, consumers can use data to maintain their own health over time.”
This shift toward prevention and system integration is reflected in PureHealth’s vision and business structure.
Its “Care & Cover” operating structure brings together insurance, hospitals, diagnostics, digital health and pharmacy services within a single network. The aim is to reduce fragmentation by aligning financing and care delivery. When the same organization both pays for care and delivers it, incentives align more closely.
“Predictive models flag risk earlier, and our Care & Cover ecosystem coordinates everything from referrals to pharmacy, to in-patient care,” says Asif. “When insurance and care are split, patients often fall through the cracks.”
The Care & Cover model is supported by Abu Dhabi’s integrated regulatory framework, which allows health innovations to be tested and deployed at scale—something fragmented health care markets struggle to achieve.
As the largest health care group in the Middle East, PureHealth is leveraging this advantage to scale preventive care, share data and integrate AI tools across its 110 hospitals and 316 clinics.
PureHealth operationalizes integration and prevention by placing AI at the core of its processes. The company has embedded artificial intelligence across its ecosystem—in hospitals, clinics, insurance platforms and digital tools.
“AI is woven into everything we do,” says Asif. “In hospitals, selected AI tools support early risk identification and help predict patient deterioration before it becomes critical. These tools are embedded into clinical decision-making to support doctors, rather than overwhelm them.”
A key example is Pura, PureHealth’s AI-enabled “healthspan” app, designed to connect prevention, clinical care and behavioral change at scale. The platform analyzes data from wearables and medical records to generate a “PureScore”—a dynamic indicator of a user’s health. Pura has now surpassed 700,000 downloads, according to company data.
Pura’s algorithm is trained on anonymized health records from its vast clinical network, and adapted for Middle East health patterns. It uses this data to provide personalized recommendations that nudge users toward healthier habits.
This approach is showing promising early results. In a 52-week pilot of 5,000 Pura users in the UAE, consistent tracking was associated with improved PureScore and broader health indicators.
“Engagement is everything in prevention,” says Asif. “The Pura platform makes health data actionable and personal.”
PureHealth uses these comprehensive, AI-driven insights to inform clinical care.
Early last year, the Department of Health Abu Dhabi licensed the Pura Longevity Clinic, PureHealth’s longevity science facility. The clinic provides diagnostics, lifestyle assessments, nutrition expertise, sleep analysis and fitness training. It complements the Pura platform by extending PureHealth’s preventive health philosophy to a clinical setting, where deeper assessments and expert-led interventions can support more tailored health journeys over time.
Dr. Lennard Lee, an Oxford University oncologist and researcher, sees this integration as health care’s future. “AI could fundamentally change patient care models,” he says. “These technologies offer advantages in real-time learning and adapting, using massive datasets to improve health interventions continuously.”
Investors and industry observers are watching how PureHealth’s model performs in different regulatory environments.
The company has expanded through major acquisitions, including acquiring Circle Health Group in the UK and Hellenic Healthcare Group in Greece and Cyprus, while also taking a minority stake in US provider Ardent Health Services.

More than simply growing its footprint, the company’s strategy aims to prove that a prevention-first model can be adapted to different markets.
Asif believes this model will define the future of health care.
“The next generation of health care systems will not be defined by how well they treat disease,” she says. “They will be defined by how effectively they prevent it.”